Rodrigues-Ferreira et al. reported that ATIP3 mRNA expression was significantly reduced in breast cancer with poor clinical outcome, and that re-expression of ATIP3 inhibited tumor cell proliferation both in vitro and in vivo [20]. Here, MTUS1 is linked to breast carcinoma.